Research Analysts’ Updated EPS Estimates for July 7th (AAL, ADBE, AGPU, ALAR, ALNY, AMRZ, ASAN, AVAV, AVGO, BEAM)

Research Analysts’ updated eps estimates for Tuesday, July 7th:

American Airlines Group (NASDAQ:AAL) was downgraded by analysts at Melius Research from a buy rating to a hold rating. They currently have $19.00 price target on the stock.

Adobe (NASDAQ:ADBE) had its underperform rating reiterated by analysts at Bank of America Corporation. Bank of America Corporation currently has a $190.00 target price on the stock.

Axe Compute (NASDAQ:AGPU) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.

Alarum Technologies (NASDAQ:ALAR) had its neutral rating reaffirmed by analysts at Alliance Global Partners.

Alnylam Pharmaceuticals (NASDAQ:ALNY) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a buy rating.

Amrize (NYSE:AMRZ) had its hold rating reaffirmed by analysts at Truist Financial Corporation. The firm currently has a $48.00 target price on the stock, down from their previous target price of $65.00.

Asana (NYSE:ASAN) had its market outperform rating reiterated by analysts at Citizens Jmp. The firm currently has a $15.00 target price on the stock.

AeroVironment (NASDAQ:AVAV) had its outperform rating reissued by analysts at Royal Bank Of Canada. They currently have a $210.00 target price on the stock.

Broadcom (NASDAQ:AVGO) had its hold rating reissued by analysts at Erste Group Bank AG.

Beam Therapeutics (NASDAQ:BEAM) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $80.00 price target on the stock.

Crinetics Pharmaceuticals (NASDAQ:CRNX) had its neutral rating reiterated by analysts at Cantor Fitzgerald.

Crinetics Pharmaceuticals (NASDAQ:CRNX) had its neutral rating reaffirmed by analysts at HC Wainwright. The firm currently has a $85.00 price target on the stock, up from their previous price target of $81.00.

Crinetics Pharmaceuticals (NASDAQ:CRNX) had its hold rating reiterated by analysts at JonesTrading. JonesTrading currently has a $85.00 target price on the stock.

Crinetics Pharmaceuticals (NASDAQ:CRNX) had its hold rating reissued by analysts at Jefferies Financial Group Inc.. They currently have a $85.00 target price on the stock, up from their previous target price of $55.00.

Crinetics Pharmaceuticals (NASDAQ:CRNX) had its market perform rating reaffirmed by analysts at Oppenheimer Holdings, Inc..

Crest Nicholson (LON:CRST) had its outperform rating reiterated by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a GBX 95 price target on the stock.

Criteo (NASDAQ:CRTO) had its buy rating reiterated by analysts at DA Davidson. DA Davidson currently has a $24.00 price target on the stock.

Walt Disney (NYSE:DIS) had its buy rating reiterated by analysts at Rosenblatt Securities. They currently have a $126.00 target price on the stock.

Ecolab (NYSE:ECL) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. The firm currently has a $337.00 target price on the stock.

Equifax (NYSE:EFX) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $265.00 target price on the stock.

Infinity Natural Resources (NYSE:INR) had its outperform rating reiterated by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $27.00 target price on the stock.

ITV (LON:ITV) was downgraded by analysts at JPMorgan Chase & Co. to a neutral rating. They currently have GBX 85 target price on the stock, down from their previous target price of GBX 104.

Invivyd (NASDAQ:IVVD) had its buy rating reissued by analysts at BTIG Research.

LENZ Therapeutics (NASDAQ:LENZ) had its buy rating reiterated by analysts at HC Wainwright.

London Stock Exchange Group (LON:LSEG) was downgraded by analysts at Citigroup Inc. to a buy rating.

Medpace (NASDAQ:MEDP) had its hold rating reissued by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a $515.00 target price on the stock, up from their previous target price of $490.00.

Marvell Technology (NASDAQ:MRVL) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $360.00 target price on the stock.

Nano-X Imaging (NASDAQ:NNOX) had its neutral rating reaffirmed by analysts at Alliance Global Partners. The firm currently has a $3.00 price target on the stock, down from their previous price target of $5.00.

O’Reilly Automotive (NASDAQ:ORLY) had its buy rating reissued by analysts at DA Davidson. The firm currently has a $114.00 target price on the stock.

PennyMac Financial Services (NYSE:PFSI) was downgraded by analysts at Barclays PLC from an overweight rating to an equal weight rating. They currently have $93.00 target price on the stock, down from their previous target price of $107.00.

CPI Card Group (NASDAQ:PMTS) had its buy rating reaffirmed by analysts at DA Davidson. DA Davidson currently has a $30.00 price target on the stock.

RxSight (NASDAQ:RXST) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $11.00 price target on the stock.

SLM (NASDAQ:SLM) had its equal weight rating reiterated by analysts at Barclays PLC. They currently have a $26.00 target price on the stock, down from their previous target price of $30.00.

Samsung Electronics (OTCMKTS:SSNLF) was downgraded by analysts at Erste Group Bank AG from a buy rating to a hold rating.

Sysco (NYSE:SYY) was downgraded by analysts at Melius Research from a hold rating to a sell rating.

Theravance Biopharma (NASDAQ:TBPH) was downgraded by analysts at HC Wainwright from a buy rating to a neutral rating. HC Wainwright currently has $17.00 target price on the stock, up from their previous target price of $15.00.

Truist Financial (NYSE:TFC) had its neutral rating reaffirmed by analysts at UBS Group AG. They currently have a $55.00 target price on the stock, down from their previous target price of $58.00.

Telix Pharmaceuticals (NASDAQ:TLX) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $20.00 target price on the stock.

Tvardi Therapeutics (NASDAQ:TVRD) had its buy rating reissued by analysts at BTIG Research. The firm currently has a $15.00 price target on the stock.

Upstart (NASDAQ:UPST) had its buy rating reissued by analysts at BTIG Research. They currently have a $43.00 price target on the stock.

Victrex (LON:VCT) had its hold rating reissued by analysts at Jefferies Financial Group Inc.. They currently have a GBX 595 price target on the stock.

Wintrust Financial (NASDAQ:WTFC) had its neutral rating reissued by analysts at UBS Group AG. They currently have a $170.00 target price on the stock.